Ulland Investment Advisors LLC Buys 52 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Ulland Investment Advisors LLC boosted its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 0.2% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 21,870 shares of the biotechnology company’s stock after purchasing an additional 52 shares during the period. Axon Enterprise comprises approximately 8.3% of Ulland Investment Advisors LLC’s portfolio, making the stock its 2nd largest position. Ulland Investment Advisors LLC’s holdings in Axon Enterprise were worth $12,998,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Quent Capital LLC grew its stake in shares of Axon Enterprise by 1,875.0% in the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after buying an additional 75 shares in the last quarter. Prestige Wealth Management Group LLC boosted its holdings in Axon Enterprise by 115.8% during the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after acquiring an additional 44 shares during the period. Brooklyn Investment Group acquired a new position in Axon Enterprise in the 3rd quarter valued at about $41,000. Planning Capital Management Corp increased its stake in Axon Enterprise by 83.3% during the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after purchasing an additional 55 shares during the period. Finally, Friedenthal Financial acquired a new stake in shares of Axon Enterprise during the third quarter worth about $51,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling at Axon Enterprise

In related news, insider Jeffrey C. Kunins sold 21,834 shares of the company’s stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total value of $12,966,775.92. Following the completion of the sale, the insider now owns 154,394 shares in the company, valued at $91,691,508.72. This represents a 12.39 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, President Joshua Isner sold 20,000 shares of the firm’s stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the transaction, the president now directly owns 208,166 shares in the company, valued at $126,179,820.90. The trade was a 8.77 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 50,545 shares of company stock worth $30,721,337 over the last 90 days. Corporate insiders own 5.70% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on AXON shares. Robert W. Baird upped their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their price objective for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Northland Securities lifted their target price on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. JMP Securities upped their price target on Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a report on Thursday, October 31st. Finally, The Goldman Sachs Group lifted their price objective on Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research note on Wednesday, October 23rd. One investment analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $504.92.

Axon Enterprise Trading Up 1.4 %

NASDAQ AXON opened at $593.89 on Tuesday. The firm’s fifty day moving average price is $616.92 and its 200 day moving average price is $463.24. Axon Enterprise, Inc. has a 12 month low of $247.04 and a 12 month high of $698.67. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The company has a market capitalization of $45.28 billion, a price-to-earnings ratio of 153.46, a price-to-earnings-growth ratio of 5.95 and a beta of 1.04.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.